Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glipizide (CP 28720) 是一种有效的、具有口服活性的磺酰脲类抗糖尿病试剂 (anti-diabetic agent),在 2 型糖尿病的研究中具有价值,但不适用于1 型糖尿病。Glipizide 是通过部分阻断郎格汉斯胰岛细胞中 ATP 敏感钾通道 (KATP)发挥活性 。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 298 | 现货 | ||
100 mg | ¥ 418 | 现货 | ||
500 mg | ¥ 587 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 460 | 现货 |
产品描述 | Glipizide (CP 28720) is a short-acting, second-generation sulfonylurea with hypoglycemic activity. |
靶点活性 | KATP:6.4 nM ATP-sensitive potassium (IC50) |
激酶实验 | The activity of caspase-3, -8 and -9 is assessed using the caspase-3, -8 and -9 colorimetric assay kits, respectively. In brief, 1×106?cells in a 60-mm culture dish are incubated with 10 mM Valproic acid for 24 h. The cells are then washed in PBS and suspended in 5 volumes of lysis buffer provided with the kit. Protein concentrations are determined using the Bradford method. Supernatants containing 50 μg total protein are used to determine caspase-3, -8 and -9 activities. The supernatants are added to each well in 96-well microtiter plates with DEVD-pNA, IETD-pNA or LEHD-pNA as caspase-3, -8 and -9 substrates and the plates are incubated at 37°C for 1 h. The optical density of each well is measured at 405 nm using a microplate reader. The activity of caspase-3, -8 and -9 is expressed in arbitrary absorbance units. |
别名 | CP 28720, K 4024, 格列吡嗪 |
分子量 | 445.54 |
分子式 | C21H27N5O4S |
CAS No. | 29094-61-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 82 mg/mL (184 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2445 mL | 11.2223 mL | 22.4447 mL | 56.1117 mL |
5 mM | 0.4489 mL | 2.2445 mL | 4.4889 mL | 11.2223 mL | |
10 mM | 0.2244 mL | 1.1222 mL | 2.2445 mL | 5.6112 mL | |
20 mM | 0.1122 mL | 0.5611 mL | 1.1222 mL | 2.8056 mL | |
50 mM | 0.0449 mL | 0.2244 mL | 0.4489 mL | 1.1222 mL | |
100 mM | 0.0224 mL | 0.1122 mL | 0.2244 mL | 0.5611 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Glipizide 29094-61-9 DNA Damage/DNA Repair Membrane transporter/Ion channel Metabolism Potassium Channel PPAR ABC CP 28720 K 4024 type 2 diabetes sulfonylurea class K ATP KcsA Inhibitor mellitus 格列吡嗪 CP-28720 inhibit K-4024 ATP-sensitive potassium CP28720 pancreatic β K4024 inhibitor